Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
Dermatol Ther (Heidelb)
.
2024 Aug;14(8):2297.
doi: 10.1007/s13555-024-01221-0.
Authors
April W Armstrong
1
,
Tarannum Jaleel
2
,
Joseph F Merola
3
,
Alice B Gottlieb
4
,
Saakshi Khattri
4
,
Cameron C Helt
5
,
William N Malatestinic
6
,
Sarah E Ross
6
,
Marcus E Ngantcha
6
,
Kurt de Vlam
7
8
Affiliations
1
University of California, Los Angeles, CA, USA.
2
Department of Dermatology, Duke University School of Medicine, Durham, NC, USA.
3
Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern, Dallas, TX, USA.
4
Department of Dermatology, Icahn School of Medicine, New York, NY, USA.
5
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
[email protected]
.
6
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
7
Department of Rheumatology, University Hospitals Leuven, Louvain, Belgium.
8
Skeletal Biology and Engineering Research Centre, Department Development and Regeneration, KU Leuven, Louvain, Belgium.
PMID:
38981938
PMCID:
PMC11333380
DOI:
10.1007/s13555-024-01221-0
No abstract available
Publication types
Published Erratum